Memory loss. Confusion. Loss of motor skills. Inability to reason logically.
And ultimately death.
This scenario describes the situation for 50 million people worldwide and counting.
They have Alzheimer’s disease.
It is a debilitating brain disorder that is now considered to be the greatest global health care challenge of the 21st century.
Existing challenges in the treatment of Alzheimer’s disease include the following:
#1 The Blood-Brain-Barrier.
Mother nature created specialized cells which surround the central nervous system, protecting it from all foreign substances. This includes making it extremely difficult for medications to cross into the brain.
#2 Hepatic First-Pass Effect.
Oral medications first get partially metabolized by the liver. This makes drugs less bioavailable to their target site.
#3 Treatment requires daily medication.
This is a huge burden for Alzheimer’s patients, who experience forgetfulness.
#4 Targeting drug delivery to the Alzheimer’s affected area of the brain.
#5 Patients are often non-compliant with medications because they are confused.
Our company will solve ALL of these challenges using nano biotechnology.